Search clinical trials for: RN1006+%28Avotermin%29

Total 105 results

Renovo

Completed

A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo (RN1006)

Scar Improvement

United Kingdom
Renovo

Completed

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

Cicatrix

United Kingdom
Renovo

Completed

Juvista in Scar Revision Surgery of Disfiguring Scars (Revise)

Cicatrix

Spain, France, Hungary, Italy, United Kingdom, United States, Denmark, Germany, Latvia, Poland
Renovo

Completed

Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing | Re-epithelialization

United Kingdom
Renovo

Completed

Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males

Cicatrix

United Kingdom
Renovo

Completed

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women

Cicatrix

United Kingdom
Renovo

Completed

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

Cicatrix

United Kingdom
Istanbul Medeniyet University

Completed

Turkish Validation and Reliability of LURN SI-29 Questionnaire in Patients With Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms | Urinary Incontinence

Turkey
Renovo

Unknown

Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.

Cicatrix

United Kingdom
Boston Scientific Corporation

Withdrawn

REPRISE EDGE 29 mm EU Study

Aortic Valve Stenosis
Renovo
ICON Clinical Research

Completed

Juvista (Avotermin) in Scars Following Varicose Vein Removal

Cicatrix | Varicose Veins

Belgium, United Kingdom, Latvia, Lithuania
Renovo

Completed

Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars

Keloid

United States
Renovo

Completed

RN1001(Avotermin) in Scar Improvement Following Breast Augmentation

Cicatrix | Mammaplasty

United Kingdom
Renovo

Terminated

Juvista (Avotermin) in Breast Reduction Surgery Scars

Cicatrix | Mammaplasty

United Kingdom
Renovo

Unknown

A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

Cicatrix | Nevus

United Kingdom
Legend Labz, Inc.

Recruiting

Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility

Safety Issues

United States
ZymoGenetics

Completed

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic

United States, Canada
Renovo

Completed

Safety of Juvista When Administered Following Excision of Ear Lobe Keloids (RN1001-0093)

Keloid

United States
Renovo

Completed

Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

Cicatrix

United Kingdom
M.D. Anderson Cancer Center

Recruiting

Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment

Pneumonia | Hematopoietic System--Cancer | Pulmonary

United States
Renovo

Completed

Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids

Keloid

United States
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Recruiting

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

Recurrent Mycosis Fungoides | Refractory Mycosis Fungoides | Stage I Mycosis Fungoides | Stage II Mycosis Fungoides | Stage III Mycosis Fungoides

United States
Renovo

Completed

Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)

Cicatrix | Wound Healing

United Kingdom
Principia Biopharma, a Sanofi Company

Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) (LUNA 3)

Immune Thrombocytopenia

United States, China, Argentina, Australia, Brazil, Canada, France, Hungary, Israel, Korea, Republic of, Mexico, Russian Federation, Singapore, Spain, Thailand, United Kingdom, Austria, Chile, Germany, Italy, Japan, Netherlands, Norway and more
Renovo

Completed

Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects

Cicatrix | Wound Healing

United Kingdom
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects

Pharmacokinetics

Canada
Renovo

Completed

Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects

Cicatrix | Re-epithelialisation

United Kingdom
Renovo

Completed

Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three Times

Cicatrix | Wound-healing

United Kingdom
Principia Biopharma, a Sanofi Company

Active, not recruiting

A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia | Immune Thrombocytopenic Purpura

United States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
National Taiwan University Hospital
National Taiwan University

Unknown

Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects

Healthy

Taiwan
Regado Biosciences, Inc.

Completed

Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD (SC101)

Healthy Volunteer

United States
Sanofi

Active, not recruiting

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

Warm Autoimmune Hemolytic Anemia (wAIHA)

United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
SmartNuclide Biopharma
The First Affiliated Hospital of Soochow University

Completed

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Solid Tumor

China
Chongqing Precision Biotech Co., Ltd

Enrolling by invitation

Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory

China
TSH Biopharm Corporation Limited

Completed

Extended-Release RANCAD in the Patients With Stable Angina Pectoris

Stable Angina Pectoris

Taiwan
Merck Sharp & Dohme LLC

Completed

A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)

Type 2 Diabetes Mellitus
Sanofi

Completed

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Atopic Dermatitis

Netherlands, Chile, United States, Canada, Czechia, Germany, Poland
Legend Labz, Inc.

Recruiting

A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects

Safety

United States
Neurimmune AG

Completed

First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy

Amyloid Transthyretin Cardiomyopathy

Germany, France, Netherlands, Spain
Celgene

Terminated

A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Myelodysplastic Syndrome

United States
National Cancer Institute, Naples

Not yet recruiting

PRO for Fighting FT in Ovarian Cancer (MITO45-ProFFiT)

Ovarian Cancer

Italy
Hacettepe University

Completed

Serum Fibroblast Growth Factor-21 Levels During Prolonged Fasting

Fasting | Fibroblast Growth Factor-21

Turkey
Principia Biopharma, a Sanofi Company
Principia Biopharma Australia Pty Ltd.

Completed

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

Pemphigus Vulgaris

Israel, Australia, Greece, Croatia, France
Dr. Reddy's Laboratories Limited

Completed

A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules

Rosacea

Germany
Journey Medical Corporation
Dr. Reddy's Laboratories Limited

Completed

A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. (MVOR-1)

Papulopustular Rosacea

United States
University of South Carolina
Susan G. Komen Breast Cancer Foundation

Completed

Brown Seaweed as a Breast Cancer Preventive

Breast Cancer

United States
BioMarck Pharmaceuticals, Ltd.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD (BREATH-1)

Chronic Obstructive Pulmonary Disease | COPD

United States

3

Subscribe